1Yuen MF,Sablon E, Hui CK, et al. Prognostic factors in severe exacerbation of chronic hepatitis B[J]. Clin Infect Dis,2003,36(8):979 - 984
2Huo TI, Wu JC, Sheng WY, et al. Survival and prognostic indicators in patients with hepatitis B virus-related cirrhosis after onset of hepatic decompensation[J]. J Gastroenterol Hepatol, 1996,11 (6): 560 - 565
2Comgan JJ. Prothrombin antigen and coagulent activity patients with liver disease[J]. JAMA, 1982,248:1736
3Comgan JJ. Factor Ⅱ antigen in liver disease and wartarin-induced Vitamin K defficiency: Correlation with coagulent activity using echis venom[J].Am J Hematol, 1980,8:249
3Stockmann HB, Hiemstra CA, Marquet RL, et al. Extracorporeal perfusion for the treatment of acute liver failure [ J ]. Ann Surg,2000,231:460-470.
4O'Grady JG. Fulminant hepatitis in patients with chronic liver disease[ J]. J Viral Hepat ,2000,7:9-10.
5Uetsuji S,Komada H,Kwon AH,et al. Assessing the eligibility for liver transplantation of patients with fulminant hepatitis [J]. Surg Today, 1997,27:186-188.
6Obuchi M, Yoshiba M, Sekiyama K, et al. Serial hepatic and splenic volumetry in acute severe hepatitis [ J ]. Nippon Shokakibyo Gakkai Zasshi, 1999,96:147-153.
7Christensen E,Bremmelgaard A, Bahnsen M. Prediction of fatality in fulminant hepatic failure[ J]. Scand J Gastroenterol,1984,19:90-96.
8Huo TI,Wu JC,Sheng WY,et al. Prognostic factor analysis of fulminant and subfulminant hepatic failure in an area endemic for hepatitis B [ J ]. J Gastroenterol Hepatol, 1996,11: 560-565.
9Acharya SK,Dasarathy S, Kumer TL,et al. Fulminant hepatitis in a tropical population:clinical course, cause, and early predictors of outcome [ J]. Hepatology, 1996,23:1448-1455.
10Y. Takada,S. Ishiguro,K. Fukunaga. Large-animal models of fulminant hepatic failure[J] 2003,Journal of Artificial Organs(1):0009～0013
